The Traditional AOR Agency Billing Trap (aka Headcount)

You’re in marketing leadership at your pharma, device, biotech, or wellness brand. You see the overages on that AOR agency bill. You think WTF?

The healthcare agency headcount trap is a systemic operational conflict built into the traditional agency business model.

At its core, the trap lies in the misalignment of incentives between a traditional agency's financial model and your brand team’s need for strategy (and often revisions) at the speed of light. They pull against each other.

Here are the 3 main traps and what to look for.

1. The Incentive Problem

Traditional agency revenue models are in direct conflict with a marketing leader’s best efforts.

You can’t be in every meeting. You can’t make every decision. So you hire or inherit staff and agencies you believe to be competent. They may very well be.

Traditional agencies tie their profitability directly to billable human hours and headcount. These dinosaur model margins scale with the team size. So they are financially incentivized to maximize the billable hours required to solve a problem.

Two things follow. First, you were hoping the agency would train your team because you learned so much from an agency, once. And now, you don’t have time. But your agency doesn’t have time, either. No one seems to have time. Almost as if by design. So, unbeknownst to you, every meeting between your agency has turned into career group therapy for your reports. Your junior team may not want to listen to your agency, because they have a hierarchy in mind. Yet, an agency with a strong finance team will leverage incentive structure to profit from your team’s mistakes.

Secondly, your brand team and your agencies now each start dancing to the violins of different agendas. People play politics with outdated knowledge. Everything spirals out of control. Some grow arrogant to compensate. Some just freeze.

This happens constantly. It leads to bad decisions. Especially when your agency won’t push back. Every brand team says they want a strategic partner when in discussions. But then later, few behave like they actually want one. When that’s true, agencies just do what they are told. It is absolutely and completely a 100% valid survival strategy to just do what the brand team tells them to do. Yes, we will use your client-prompted AI copy. Yes, we will add some punch. Yes, we can make the logo pop. Sure thing.

If your agency profits more from a brand team’s mistake than from preventing it, that’s no scandal. That’s just a harsh reality of a business model working as designed.

You may not like it. Your agency account/pm/creative peeps may not like it. Finance isn’t going to be mad about it. I’m thinking agency leadership kinda loves it. It’s a systemic issue.

2. Oh, They’re Multiplying!

A traditional agency invoice—any $50,000+ project, take your pick—tends to break down something like this, in my overall experience:

• 10% Senior Strategy: The high-level partners, strategists, or creative directors who won the pitch, but rarely touch the day-to-day work.

• 40% Workflow Coordination: Mid-level managers whose main function is routing emails, scheduling meetings, attending meetings, talking about meetings, and managing internal agency politics.

• 50% Under-Resourced Junior Execution: Junior associates learning the complexities of healthcare.

The Headcount Disparity on Invoices

A traditional agency’s invoice is structurally weighted toward administrative overhead and junior staff retention. Meaning, they get the bulk of the hours. No fault of theirs. Just note that in this model, it does not go to elite strategy and creative hours. This is why elite healthcare marketers have always had to work with consultants and boutique shops.

Multiplying the Multipliers

So, when you join that agency call and all of the sudden you’re surprised by the number of faces you’re seeing and you’re wondering who they all are, that’s who they all are. 

3. The Existential Threat of Efficiency

Traditional agencies make more money when projects require heavy, multi-layered coordination. So operational efficiency becomes an existential enemy. A lean, senior-led team with the right tools can solve a positioning or messaging bottleneck instantly, but that collapses the agency's billing potential.

No agency is incentivized to build a tool that puts itself out of work. With senior-led, value based pricing models, pharma brands save massive amounts of money and time and respond faster, and hopefully better, to market dynamics. Similar to how bankers, investors, and lawyers structure businesses in those fields. Reward goes to those that produce value and efficiency.

The Strategic Alternative

The independent model has always existed as an alternative. And some brands know the modern alternative to the headcount trap is simply in bypassing the traditional standing army model. Entirely. 

For years, there’s been a pattern across large pharma with brand teams pulling strategic ownership in-house rather than parking it with an AOR. By standing up senior-led, embedded pods and building highly specialized, agile units that prioritize strategic speed and direct execution over administrative billable layers. What's shifting now is scale. It takes the right people and the right process to succeed.

When it succeeds, it funds direct, strategic, brand ownership instead of gilding an agency’s office in gold effect.

Traditional agencies bolt AI prompts onto the same old process. That's not transformation. That's just more decoration.

Real transformation designs the workflow around depth, detail, speed, and sustainability. From the ground up. 

That’s what I was taught real agencies are always supposed to do.